Your browser doesn't support javascript.
loading
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.
Tariq, K; Schofield, J P R; Nicholas, B L; Burg, D; Brandsma, J; Bansal, A T; Wilson, S J; Lutter, R; Fowler, S J; Caruso, M; Dahlen, B; Horváth, I; Krug, N; Montuschi, P; Sanak, M; Sandström, T; Geiser, T; Pandis, I; Sousa, A R; Adcock, I M; Shaw, D E; Auffray, C; Howarth, P H; Sterk, P J; Chung, K F; Skipp, P J; Dimitrov, B; Djukanovic, R.
Afiliação
  • Tariq K; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Clinical Experimental Sciences Unit, Faculty of Medicine, University of Southampton, University Hospital Southampton, South Academic Block, Southampton, UK.
  • Schofield JPR; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Centre for Proteomic Research, University of Southampton, Highfield, Southampton, UK.
  • Nicholas BL; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Clinical Experimental Sciences Unit, Faculty of Medicine, University of Southampton, University Hospital Southampton, South Academic Block, Southampton, UK.
  • Burg D; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Centre for Proteomic Research, University of Southampton, Highfield, Southampton, UK.
  • Brandsma J; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
  • Bansal AT; Acclarogen Ltd, Cambridge, UK.
  • Wilson SJ; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
  • Lutter R; AMC, Department of Experimental Immunology, University of Amsterdam, Amsterdam, the Netherlands; AMC, Department of Respiratory Medicine, University of Amsterdam, Amsterdam, the Netherlands.
  • Fowler SJ; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK.
  • Bakke; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Caruso M; Dept. of Clinical and Experimental Medicine Hospital University, Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.
  • Dahlen B; Division of Respiratory Medicine and Allergy, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Horváth I; Dept. of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Krug N; Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Hannover, Germany.
  • Montuschi P; Dept. of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
  • Sanak M; Division of Molecular Biology and Clinical Genetics, Medical College, Jagiellonian University Medical College, Krakow, Poland.
  • Sandström T; Dept. of Medicine, Dept of Public Health and Clinical Medicine Respiratory Medicine Unit, Umeå University, Umeå, Sweden.
  • Geiser T; University Hospital Bern, Bern, Switzerland.
  • Pandis I; Data Science Institute, Imperial College, London, UK.
  • Sousa AR; Respiratory Therapeutic Unit, GSK, Stockley Park, UK.
  • Adcock IM; Cell and Molecular Biology Group, Airways Disease Section, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London, UK.
  • Shaw DE; Respiratory Research Unit, University of Nottingham, Nottingham, UK.
  • Auffray C; European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Lyon, France.
  • Howarth PH; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Clinical Experimental Sciences Unit, Faculty of Medicine, University of Southampton, University Hospital Southampton, South Academic Block, Southampton, UK.
  • Sterk PJ; AMC, Department of Respiratory Medicine, University of Amsterdam, Amsterdam, the Netherlands.
  • Chung KF; Airways Disease, National Heart and Lung Institute, Imperial College, London & Royal Brompton NIHR Biomedical Research Unit, London, United Kingdom.
  • Skipp PJ; Centre for Proteomic Research, University of Southampton, Highfield, Southampton, UK.
  • Dimitrov B; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
  • Djukanovic R; NIHR Southampton Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Clinical Experimental Sciences Unit, Faculty of Medicine, University of Southampton, University Hospital Southampton, South Academic Block, Southampton, UK. Electronic address: rd1@soton.ac.uk.
Respir Med ; 150: 66-73, 2019 04.
Article em En | MEDLINE | ID: mdl-30961953
ABSTRACT
Gastro-oesophageal reflux disease (GORD) has long been associated with poor asthma control without an established cause-effect relationship. 610 asthmatics (421 severe/88 mild-moderate) and 101 healthy controls were assessed clinically and a subset of 154 severe asthmatics underwent proteomic analysis of induced sputum using untargeted mass spectrometry, LC-IMS-MSE. Univariate and multiple logistic regression analyses (MLR) were conducted to identify proteins associated with GORD in this cohort. When compared to mild/moderate asthmatics and healthy individuals, respectively, GORD was three- and ten-fold more prevalent in severe asthmatics and was associated with increased asthma symptoms and oral corticosteroid use, poorer quality of life, depression/anxiety, obesity and symptoms of sino-nasal disease. Comparison of sputum proteomes in severe asthmatics with and without active GORD showed five differentially abundant proteins with described roles in anti-microbial defences, systemic inflammation and epithelial integrity. Three of these were associated with active GORD by multiple linear regression

analysis:

Ig lambda variable 1-47 (p = 0·017) and plasma protease C1 inhibitor (p = 0·043), both in lower concentrations, and lipocalin-1 (p = 0·034) in higher concentrations in active GORD. This study provides evidence which suggests that reflux can cause subtle perturbation of proteins detectable in the airways lining fluid and that severe asthmatics with GORD may represent a distinct phenotype of asthma.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Escarro / Refluxo Gastroesofágico / Proteômica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Escarro / Refluxo Gastroesofágico / Proteômica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article